MedPath
HSA Approval

MEIJUMET PROLONGED RELEASE TABLET 1000MG

SIN15470P

MEIJUMET PROLONGED RELEASE TABLET 1000MG

MEIJUMET PROLONGED RELEASE TABLET 1000MG

April 26, 2018

PHARMAZEN MEDICALS PTE LTD

PHARMAZEN MEDICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAZEN MEDICALS PTE LTD
Licence HolderPHARMAZEN MEDICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, EXTENDED RELEASE

ORAL

Medical Information

A10BA02

metformin

Manufacturer Information

PHARMAZEN MEDICALS PTE LTD

Medreich Limited

Active Ingredients

Metformin 780mg eqv Metformin Hydrochloride

1000mg

Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEIJUMET PROLONGED RELEASE TABLET 1000MG - HSA Approval | MedPath